Home LiteratureArticle Details
PMID: 495566 Published · ppublish English Journal Article

Opportunistic fungal infection among cancer patients. A ten-year autopsy study.

American journal of clinical pathology ·Vol. 72 ·No. 4 ·1979-10-00 ·Pages 617-21

Cho SY, Choi HY

Abstract

A high incidence of opportunistic fungal infections among cancer patients has been a pressing problem confronting clinicians. The fungal infections in 3,278 consecutive autopsies at Thomas Jefferson University Hospital during a ten-year period (1966-1975) were studied. There were 1,204 (36.7%) cancer patients; 85 (7.1%) of these patients had concomitant fungal infections. The incidence was 9.3% during the last five-year period; 5.1% during the first five-year period. Candidiasis was the most frequent fungal infection (52.2%) among these patients, followed by aspergillosis (31.1%), mucormycosis, cryptococcosis, histoplasmosis and nocardiosis. The leukemias and lymphomas were the most frequent malignancies associated with fungal infections. However, in this study, unlike others, the incidences of fungal infection in patients with some solid tumors were also high, especially those in patients with cancers of the colon and pancreas.

MeSH Terms
Adolescent Adult Aged Aspergillosis/complications,pathology Autopsy Candidiasis/complications,pathology Child Child, Preschool Female Humans Infant Infant, Newborn Male Middle Aged Mycoses/complications,pathology Neoplasms/complications,pathology
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Cho S Y
Choi H Y
Article Info
Journal
American journal of clinical pathology
Abbr.
Am J Clin Pathol
ISSN
0002-9173
Published
1979-10-00
Pages
617-21
Language
English
Region
England
NLM ID
0370470
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com